Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?

The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose programs for tackling omicron endemics. Despite early findings shows that booster doses may improve omicron protection, more research is needed to establish vaccination efficacy. This short communication tries to critically discuss the research work findings around booster dose strategy for omicron endemics.

Automated summary

The Omicron variant of SARS-CoV-2 is spreading in communities where previous infections and vaccinations have taken place. Over 130 countries have implemented booster dose programs to combat the Omicron variant. While early findings suggest that booster doses may enhance protection against Omicron, further research is needed to determine the efficacy of vaccines. This short communication critically discusses research findings on the booster dose strategy for Omicron.